How to buy 9 Meters Biopharma stock

9 Meters Biopharma Inc is a business based in the US. 9 Meters Biopharma shares (INNT) are listed on the NASDAQ and all prices are listed in US Dollars. 9 Meters Biopharma employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

9 Meters Biopharma stock price (NASDAQ: INNT)

Use our graph to track the performance of INNT stocks over time.

9 Meters Biopharma shares at a glance

• Key figures

Information last updated 2021-01-23.

52-week range	$0.69 - $0.84
50-day moving average	$0.73
200-day moving average	$0.61
Wall St. target price	$10.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.49

Buy 9 Meters Biopharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy 9 Meters Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

9 Meters Biopharma financials

Gross profit TTM	$0
Return on assets TTM	-193.21%
Return on equity TTM	0%
Profit margin	0%
Book value	$0.14
Market capitalisation	$23.1 million

TTM: trailing 12 months

Shorting 9 Meters Biopharma shares

There are currently 2.2 million 9 Meters Biopharma shares held short by investors – that's known as 9 Meters Biopharma's "short interest". This figure is 1.7% down from 2.2 million last month.

There are a few different ways that this level of interest in shorting 9 Meters Biopharma shares can be evaluated.

9 Meters Biopharma's "short interest ratio" (SIR)

9 Meters Biopharma's "short interest ratio" (SIR) is the quantity of 9 Meters Biopharma shares currently shorted divided by the average quantity of 9 Meters Biopharma shares traded daily (recently around 519741.86602871). 9 Meters Biopharma's SIR currently stands at 4.18. In other words for every 100,000 9 Meters Biopharma shares traded daily on the market, roughly 4180 shares are currently held short.

However 9 Meters Biopharma's short interest can also be evaluated against the total number of 9 Meters Biopharma shares, or, against the total number of tradable 9 Meters Biopharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 9 Meters Biopharma's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 9 Meters Biopharma shares in existence, roughly 30 shares are currently held short) or 0.027% of the tradable shares (for every 100,000 tradable 9 Meters Biopharma shares, roughly 27 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 9 Meters Biopharma.

Find out more about how you can short 9 Meters Biopharma stock.

9 Meters Biopharma share dividends

We're not expecting 9 Meters Biopharma to pay a dividend over the next 12 months.

Have 9 Meters Biopharma's shares ever split?

9 Meters Biopharma's shares were split on a 1:10 basis on 31 January 2018. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your 9 Meters Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for 9 Meters Biopharma shares which in turn could have impacted 9 Meters Biopharma's share price.

9 Meters Biopharma share price volatility

Over the last 12 months, 9 Meters Biopharma's shares have ranged in value from as little as $0.6858 up to $0.835. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 9 Meters Biopharma's is -0.5435. This would suggest that 9 Meters Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, 9 Meters Biopharma has bucked the trend.

9 Meters Biopharma overview

9 Meters Biopharma, Inc. operates as a rare, orphan, and unmet needs-focused GI company. The company is advancing its drug candidates for short bowel syndrome and celiac disease. Its product candidates include NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for short bowel syndrome; and larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease. The company's pipeline products also includes NM-004, an oral gut restricted immunomodulator and NM-003, a long-acting GLP-2 analogue, both of which are under orphan indication selection. 9 Meters Biopharma, Inc. owns global rights to its products.

Frequently asked questions

What percentage of 9 Meters Biopharma is owned by insiders or institutions?
Currently 10.237% of 9 Meters Biopharma shares are held by insiders and 2.733% by institutions. How many people work for 9 Meters Biopharma?
Latest data suggests 8 work at 9 Meters Biopharma. When does the fiscal year end for 9 Meters Biopharma?
9 Meters Biopharma's fiscal year ends in December. Where is 9 Meters Biopharma based?
9 Meters Biopharma's address is: 8480 Honeycutt Road, Raleigh, NC, United States, 27615 What is 9 Meters Biopharma's ISIN number?
9 Meters Biopharma's international securities identification number is: US6544051096 What is 9 Meters Biopharma's CUSIP number?
9 Meters Biopharma's Committee on Uniform Securities Identification Procedures number is: 45782F105